Ischemic Stroke and Activated Protein C Resistance
| Autor: | Robin Dhote, Jean-Louis Mas, Claude Bachmeyer, Boyan Christoforov, Mathieu Zuber, Pierre Toulon |
|---|---|
| Rok vydání: | 1995 |
| Předmět: |
medicine.medical_specialty
medicine.drug_class Thrombophilia Internal medicine medicine Factor V Leiden Humans biology medicine.diagnostic_test Cerebral infarction business.industry Anticoagulant Factor V Magnetic resonance imaging General Medicine Blood Coagulation Disorders medicine.disease Surgery Cerebrovascular Disorders biology.protein Cardiology Activated protein C resistance business Protein C medicine.drug |
| Zdroj: | JAMA: The Journal of the American Medical Association. 274:1266 |
| ISSN: | 0098-7484 |
| Popis: | To the Editor. —A poor anticoagulant response to activated protein C (APC) has been reported to be the most common identified coagulation defect in patients with thrombophilia. 1-3 The molecular basis of APC resistance was identified in most patients as a single G-to-A substitution at position 1691 in the factor V gene, described as factor V Leiden. 4 The resulting Arg-to-Gln mutation at position 506, the APC cleavage site in factor Va, leads to an unregulated activation of coagulation. The cause of ischemic stroke often remains unknown, despite extensive investigations. The association with hypercoagulable states has rarely been reported. 5 We report two cases of ischemic stroke associated with APC resistance. Report of Cases.—Case 1. —A 64-year-old nonsmoking woman developed sudden onset of right complete hemiplegia and aphasia. A computed tomographic scan and magnetic resonance imaging of the head disclosed a large cerebral infarction in the left middle |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|